Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by ISSAM I RAAD and RAY Y HACHEM.
ISSAM I RAAD
Connection Strength
22.889
RAY Y HACHEM
  1. Novel antimicrobial ointment for infected wound healing in an in vitro and in vivo porcine model. Wound Repair Regen. 2021 09; 29(5):830-842.
    View in: PubMed
    Score: 0.776
  2. International Multicenter Experience in the Treatment Outcome of Invasive Aspergillosis in Immunocompromised Cancer Patients. Mediterr J Hematol Infect Dis. 2019; 11(1):e2019003.
    View in: PubMed
    Score: 0.660
  3. Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies. Int J Antimicrob Agents. 2017 Sep; 50(3):384-388.
    View in: PubMed
    Score: 0.595
  4. Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Clinical Bacteria Isolated from Patients with Cancer. Antimicrob Agents Chemother. 2017 04; 61(4).
    View in: PubMed
    Score: 0.583
  5. Successful Salvage of Central Venous Catheters in Patients with Catheter-Related or Central Line-Associated Bloodstream Infections by Using a Catheter Lock Solution Consisting of Minocycline, EDTA, and 25% Ethanol. Antimicrob Agents Chemother. 2016 06; 60(6):3426-32.
    View in: PubMed
    Score: 0.551
  6. Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies. Int J Antimicrob Agents. 2015 Mar; 45(3):283-8.
    View in: PubMed
    Score: 0.492
  7. Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy. J Antimicrob Chemother. 2014 Nov; 69(11):3148-55.
    View in: PubMed
    Score: 0.483
  8. Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: outcomes and complications. Ann Oncol. 2013 Jul; 24(7):1873-1879.
    View in: PubMed
    Score: 0.442
  9. Chelator-based catheter lock solutions in eradicating organisms in biofilm. Antimicrob Agents Chemother. 2013 Jan; 57(1):586-8.
    View in: PubMed
    Score: 0.429
  10. Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi. Antimicrob Agents Chemother. 2012 Feb; 56(2):935-41.
    View in: PubMed
    Score: 0.403
  11. Novel antiseptic urinary catheters for prevention of urinary tract infections: correlation of in vivo and in vitro test results. Antimicrob Agents Chemother. 2009 Dec; 53(12):5145-9.
    View in: PubMed
    Score: 0.348
  12. The role of chelators in preventing biofilm formation and catheter-related bloodstream infections. Curr Opin Infect Dis. 2008 Aug; 21(4):385-92.
    View in: PubMed
    Score: 0.320
  13. Anti-adherence activity and antimicrobial durability of anti-infective-coated catheters against multidrug-resistant bacteria. J Antimicrob Chemother. 2008 Oct; 62(4):746-50.
    View in: PubMed
    Score: 0.320
  14. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer. 2008 Jun; 112(11):2493-9.
    View in: PubMed
    Score: 0.317
  15. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy. Cancer. 2008 Mar 15; 112(6):1282-7.
    View in: PubMed
    Score: 0.312
  16. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin. Leukemia. 2008 Mar; 22(3):496-503.
    View in: PubMed
    Score: 0.307
  17. Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients. Antimicrob Agents Chemother. 2007 Jun; 51(6):1905-11.
    View in: PubMed
    Score: 0.292
  18. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother. 2007 May; 51(5):1656-60.
    View in: PubMed
    Score: 0.291
  19. Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm. Antimicrob Agents Chemother. 2007 Jan; 51(1):78-83.
    View in: PubMed
    Score: 0.284
  20. EDTA as an adjunct antifungal agent for invasive pulmonary aspergillosis in a rodent model. Antimicrob Agents Chemother. 2006 May; 50(5):1823-7.
    View in: PubMed
    Score: 0.274
  21. Clinical and radiologic predictors of invasive pulmonary aspergillosis in cancer patients: should the European Organization for Research and Treatment of Cancer/Mycosis Study Group (EORTC/MSG) criteria be revised? Cancer. 2006 Apr 01; 106(7):1581-6.
    View in: PubMed
    Score: 0.273
  22. Procalcitonin Level Monitoring in Antibiotic De-Escalation and Stewardship Program for Patients with Cancer and Febrile Neutropenia. Cancers (Basel). 2024 Oct 11; 16(20).
    View in: PubMed
    Score: 0.246
  23. Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies. Cancer. 2004 Oct 01; 101(7):1594-600.
    View in: PubMed
    Score: 0.246
  24. Impact of surveillance for vancomycin-resistant enterococci on controlling a bloodstream outbreak among patients with hematologic malignancy. Infect Control Hosp Epidemiol. 2004 May; 25(5):391-4.
    View in: PubMed
    Score: 0.239
  25. In vitro activity of cefepime/taniborbactam and comparator agents against Gram-negative bacterial bloodstream pathogens recovered from patients with cancer. JAC Antimicrob Resist. 2024 Apr; 6(2):dlae060.
    View in: PubMed
    Score: 0.238
  26. Comparing Molnupiravir to Nirmatrelvir/Ritonavir (Paxlovid) in the Treatment of Mild-to-Moderate COVID-19 in Immunocompromised Cancer Patients. Cancers (Basel). 2024 Mar 05; 16(5).
    View in: PubMed
    Score: 0.236
  27. In vitro activity of tebipenem and comparator agents against bacterial pathogens isolated from patients with cancer. JAC Antimicrob Resist. 2023 Dec; 5(6):dlad132.
    View in: PubMed
    Score: 0.232
  28. Evaluation of the silver iontophoretic catheter in an animal model. Biomaterials. 2003 Sep; 24(20):3619-22.
    View in: PubMed
    Score: 0.228
  29. Myelosuppression and serotonin syndrome associated with concurrent use of linezolid and selective serotonin reuptake inhibitors in bone marrow transplant recipients. Clin Infect Dis. 2003 Jul 01; 37(1):e8-11.
    View in: PubMed
    Score: 0.225
  30. Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period. Elife. 2023 02 07; 12.
    View in: PubMed
    Score: 0.219
  31. Procalcitonin for antimicrobial stewardship among cancer patients admitted with COVID-19. Elife. 2022 12 21; 11.
    View in: PubMed
    Score: 0.217
  32. Prevention of device-related infections in patients with cancer: Current practice and future horizons. CA Cancer J Clin. 2023 03; 73(2):147-163.
    View in: PubMed
    Score: 0.214
  33. A Prospective Randomized Study Comparing Ceftolozane/Tazobactam to Standard of Care in the Management of Neutropenia and Fever in Patients With Hematological Malignancies. Open Forum Infect Dis. 2022 Jun; 9(6):ofac079.
    View in: PubMed
    Score: 0.205
  34. Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant. J Fungi (Basel). 2022 Jan 13; 8(1).
    View in: PubMed
    Score: 0.204
  35. Prevention and management of long-term catheter related infections in cancer patients. Cancer Invest. 2002; 20(7-8):1105-13.
    View in: PubMed
    Score: 0.203
  36. Failure of oral antimicrobial agents in eradicating gastrointestinal colonization with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol. 2002 Jan; 23(1):43-4.
    View in: PubMed
    Score: 0.203
  37. Impact of Checkpoint Inhibitor Immunotherapy, Primarily Pembrolizumab, on Infection Risk in Patients With Advanced Lung Cancer: A Comparative Retrospective Cohort Study. Clin Infect Dis. 2021 11 02; 73(9):e2697-e2704.
    View in: PubMed
    Score: 0.201
  38. The role of procalcitonin in identifying high-risk cancer patients with febrile neutropenia: A useful alternative to the multinational association for supportive care in cancer score. Cancer Med. 2021 12; 10(23):8475-8482.
    View in: PubMed
    Score: 0.201
  39. Management of enterococcal central line-associated bloodstream infections in patients with cancer. BMC Infect Dis. 2021 Jul 05; 21(1):643.
    View in: PubMed
    Score: 0.196
  40. Is a single dose of mRNA vaccine sufficient for COVID-19 survivors? J Med Virol. 2021 Jul; 93(7):4083-4084.
    View in: PubMed
    Score: 0.192
  41. Enhanced Biofilm Eradication and Reduced Cytotoxicity of a Novel Polygalacturonic and Caprylic Acid Wound Ointment Compared with Common Antiseptic Ointments. Biomed Res Int. 2021; 2021:2710484.
    View in: PubMed
    Score: 0.191
  42. Impact of Catheter Management on Clinical Outcome in Adult Cancer Patients With Gram-Negative Bacteremia. Open Forum Infect Dis. 2019 Oct; 6(10):ofz357.
    View in: PubMed
    Score: 0.174
  43. Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective for In Vitro Eradication of Candida auris Biofilm. Antimicrob Agents Chemother. 2019 07; 63(7).
    View in: PubMed
    Score: 0.170
  44. Advances in the prevention and management of central-line-associated bloodstream infections: The role of chelator-based catheter locks. Infect Control Hosp Epidemiol. 2019 09; 40(9):1036-1045.
    View in: PubMed
    Score: 0.170
  45. Corrigendum to "Can procalcitonin differentiate Staphylococcus aureus from coagulase-negative staphylococci in clustered gram-positive bacteremia?" [Diagn Microbiol Infect Dis 2019;76(2):158-161]. Diagn Microbiol Infect Dis. 2019 05; 94(1):105.
    View in: PubMed
    Score: 0.167
  46. Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies. BMC Infect Dis. 2018 Dec 13; 18(1):656.
    View in: PubMed
    Score: 0.164
  47. Catheter-Related Staphylococcus aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation Therapy and Duration of Intravenous Antibiotic Therapy. Open Forum Infect Dis. 2018 Oct; 5(10):ofy249.
    View in: PubMed
    Score: 0.162
  48. Biomarkers of Sepsis and Bloodstream Infections: The Role of Procalcitonin and Proadrenomedullin With Emphasis in Patients With Cancer. Clin Infect Dis. 2018 08 31; 67(6):971-977.
    View in: PubMed
    Score: 0.161
  49. Changing Epidemiology of Catheter-Related Bloodstream Infections in Cancer Patients. Infect Control Hosp Epidemiol. 2018 06; 39(6):727-729.
    View in: PubMed
    Score: 0.158
  50. Author Correction: Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia. Sci Rep. 2018 Apr 19; 8(1):6258.
    View in: PubMed
    Score: 0.157
  51. Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia. Sci Rep. 2018 01 18; 8(1):1099.
    View in: PubMed
    Score: 0.154
  52. Unnecessary Removal of Central Venous Catheters in Cancer Patients with Bloodstream Infections. Infect Control Hosp Epidemiol. 2018 02; 39(2):222-225.
    View in: PubMed
    Score: 0.154
  53. Caprylic and Polygalacturonic Acid Combinations for Eradication of Microbial Organisms Embedded in Biofilm. Front Microbiol. 2017; 8:1999.
    View in: PubMed
    Score: 0.152
  54. Correction for Chaftari et al., "A Novel Nonantibiotic Nitroglycerin-Based Catheter Lock Solution for Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients". Antimicrob Agents Chemother. 2017 08; 61(8).
    View in: PubMed
    Score: 0.149
  55. A Novel Nonantibiotic Nitroglycerin-Based Catheter Lock Solution for Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients. Antimicrob Agents Chemother. 2017 07; 61(7).
    View in: PubMed
    Score: 0.148
  56. Improvement in the diagnosis of catheter-related bloodstream infections in a tertiary cancer center. Am J Infect Control. 2017 Mar 01; 45(3):e34-e39.
    View in: PubMed
    Score: 0.145
  57. Comparative Efficacies of Antimicrobial Catheter Lock Solutions for Fungal Biofilm Eradication in an in Vitro Model of Catheter-Related Fungemia. J Fungi (Basel). 2017 Feb 10; 3(1).
    View in: PubMed
    Score: 0.145
  58. In Vitro Assessment of the Antimicrobial Efficacy of Optimized Nitroglycerin-Citrate-Ethanol as a Nonantibiotic, Antimicrobial Catheter Lock Solution for Prevention of Central Line-Associated Bloodstream Infections. Antimicrob Agents Chemother. 2016 09; 60(9):5175-81.
    View in: PubMed
    Score: 0.140
  59. Mycobacterium arupense in Cancer Patients: An Emerging Infection or a Commensal Organism. Medicine (Baltimore). 2016 Apr; 95(14):e2691.
    View in: PubMed
    Score: 0.136
  60. The influence of using antibiotic-coated peripherally inserted central catheters on decreasing the risk of central line-associated bloodstream infections. Am J Infect Control. 2016 09 01; 44(9):1037-40.
    View in: PubMed
    Score: 0.135
  61. In vivo biocompatibility and in vitro efficacy of antimicrobial gendine-coated central catheters. Antimicrob Agents Chemother. 2015 Sep; 59(9):5611-8.
    View in: PubMed
    Score: 0.129
  62. Development of Gendine-Coated Cannula for Continuous Subcutaneous Insulin Infusion for Extended Use. Antimicrob Agents Chemother. 2015 Aug; 59(8):4397-402.
    View in: PubMed
    Score: 0.128
  63. The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer*. Crit Care Med. 2014 Dec; 42(12):2500-7.
    View in: PubMed
    Score: 0.124
  64. The use of minocycline-rifampin coated central venous catheters for exchange of catheters in the setting of staphylococcus aureus central line associated bloodstream infections. BMC Infect Dis. 2014 Sep 24; 14:518.
    View in: PubMed
    Score: 0.123
  65. Prevention of transmission of multidrug-resistant organisms during catheter exchange using antimicrobial catheters. Antimicrob Agents Chemother. 2014 Sep; 58(9):5291-6.
    View in: PubMed
    Score: 0.121
  66. Insights on the role of antimicrobial cuffed endotracheal tubes in preventing transtracheal transmission of VAP pathogens from an in vitro model of microaspiration and microbial proliferation. Biomed Res Int. 2014; 2014:120468.
    View in: PubMed
    Score: 0.119
  67. Central line-associated bloodstream infections caused by Staphylococcus aureus in cancer patients: Clinical outcome and management. Ann Med. 2014 May; 46(3):163-8.
    View in: PubMed
    Score: 0.117
  68. Disposable gendine antimicrobial gloves for preventing transmission of pathogens in health care settings. Am J Infect Control. 2014 Jan; 42(1):55-9.
    View in: PubMed
    Score: 0.117
  69. Prevention of biofilm colonization by Gram-negative bacteria on minocycline-rifampin-impregnated catheters sequentially coated with chlorhexidine. Antimicrob Agents Chemother. 2014; 58(2):1179-82.
    View in: PubMed
    Score: 0.115
  70. Glyceryl trinitrate complements citrate and ethanol in a novel antimicrobial catheter lock solution to eradicate biofilm organisms. Antimicrob Agents Chemother. 2013 Aug; 57(8):3555-60.
    View in: PubMed
    Score: 0.112
  71. Can procalcitonin differentiate Staphylococcus aureus from coagulase-negative staphylococci in clustered gram-positive bacteremia? Diagn Microbiol Infect Dis. 2013 06; 76(2):158-61.
    View in: PubMed
    Score: 0.111
  72. Rapidly growing mycobacterial bloodstream infections. Lancet Infect Dis. 2013 Feb; 13(2):166-74.
    View in: PubMed
    Score: 0.109
  73. Pro-adrenomedullin as a novel biomarker for predicting infections and response to antimicrobials in febrile patients with hematologic malignancies. Clin Infect Dis. 2013 Apr; 56(7):943-50.
    View in: PubMed
    Score: 0.109
  74. Management of rapidly growing mycobacterial bacteremia in cancer patients. Clin Infect Dis. 2013 Mar; 56(6):843-6.
    View in: PubMed
    Score: 0.109
  75. Nephrostomy tube related pyelonephritis in patients with cancer: epidemiology, infection rate and risk factors. J Urol. 2013 Jan; 189(1):130-5.
    View in: PubMed
    Score: 0.108
  76. Comparison of posaconazole versus weekly amphotericin B lipid complex for the prevention of invasive fungal infections in hematopoietic stem-cell transplantation. Transplantation. 2012 Aug 15; 94(3):302-8.
    View in: PubMed
    Score: 0.106
  77. Can procalcitonin distinguish infectious fever from tumor-related fever in non-neutropenic cancer patients? Cancer. 2012 Dec 01; 118(23):5823-9.
    View in: PubMed
    Score: 0.104
  78. Hospital environment and invasive aspergillosis in patients with hematologic malignancy. Am J Infect Control. 2012 Apr; 40(3):247-9.
    View in: PubMed
    Score: 0.103
  79. Rhodococcus bacteremia in cancer patients is mostly catheter related and associated with biofilm formation. PLoS One. 2012; 7(3):e32945.
    View in: PubMed
    Score: 0.103
  80. Panton Valentine Leukocidin exotoxin has no effect on the outcome of cancer patients with methicillin-resistant Staphylococcus aureus (MRSA) infections. Medicine (Baltimore). 2011 Sep; 90(5):312-318.
    View in: PubMed
    Score: 0.099
  81. Central venous catheter-associated Nocardia bacteremia in cancer patients. Emerg Infect Dis. 2011 Sep; 17(9):1651-8.
    View in: PubMed
    Score: 0.099
  82. Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles. Oncologist. 2011; 16(7):1049-60.
    View in: PubMed
    Score: 0.098
  83. The prevention of biofilm colonization by multidrug-resistant pathogens that cause ventilator-associated pneumonia with antimicrobial-coated endotracheal tubes. Biomaterials. 2011 Apr; 32(11):2689-94.
    View in: PubMed
    Score: 0.095
  84. Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: more than 0.5 million catheter days and 7 years of clinical experience. Crit Care Med. 2011 Feb; 39(2):245-51.
    View in: PubMed
    Score: 0.095
  85. Novel approach using antimicrobial catheters to improve the management of central line-associated bloodstream infections in cancer patients. Cancer. 2011 Jun 01; 117(11):2551-8.
    View in: PubMed
    Score: 0.094
  86. Does combination of lipid formulation of amphotericin B and echinocandins improve outcome of invasive aspergillosis in hematological malignancy patients? Cancer. 2010 Nov 15; 116(22):5290-6.
    View in: PubMed
    Score: 0.094
  87. Comparing quantitative culture of a blood sample obtained through the catheter with differential time to positivity in establishing a diagnosis of catheter-related bloodstream infection. Infect Control Hosp Epidemiol. 2010 Oct; 31(10):1089-91.
    View in: PubMed
    Score: 0.093
  88. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents. 2010 Aug; 36(2):182-6.
    View in: PubMed
    Score: 0.091
  89. Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms. Cancer. 2010 Feb 15; 116(4):967-73.
    View in: PubMed
    Score: 0.089
  90. Characteristics and outcomes of methicillin-resistant Staphylococcus aureus surgical-site infections in patients with cancer: a case-control study. Ann Surg Oncol. 2010 Jun; 17(6):1499-506.
    View in: PubMed
    Score: 0.089
  91. Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: remove or retain? Clin Infect Dis. 2009 Oct 15; 49(8):1187-94.
    View in: PubMed
    Score: 0.087
  92. Management of Bacillus bacteremia: the need for catheter removal. Medicine (Baltimore). 2009 Sep; 88(5):279-283.
    View in: PubMed
    Score: 0.086
  93. Differentiating culture samples representing coagulase-negative staphylococcal bacteremia from those representing contamination by use of time-to-positivity and quantitative blood culture methods. J Clin Microbiol. 2009 Oct; 47(10):3255-60.
    View in: PubMed
    Score: 0.086
  94. Tigecycline use in cancer patients with serious infections: a report on 110 cases from a single institution. Medicine (Baltimore). 2009 Jul; 88(4):211-220.
    View in: PubMed
    Score: 0.085
  95. Multidrug-resistant Escherichia coli bacteremia in cancer patients. Am J Infect Control. 2009 Nov; 37(9):741-5.
    View in: PubMed
    Score: 0.085
  96. Efficacy of novel antimicrobial gloves impregnated with antiseptic dyes in preventing the adherence of multidrug-resistant nosocomial pathogens. Am J Infect Control. 2009 May; 37(4):294-300.
    View in: PubMed
    Score: 0.083
  97. The crucial role of catheters in micrococcal bloodstream infections in cancer patients. Infect Control Hosp Epidemiol. 2009 Jan; 30(1):83-5.
    View in: PubMed
    Score: 0.082
  98. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients. Am J Infect Control. 2009 Aug; 37(6):442-6.
    View in: PubMed
    Score: 0.082
  99. The role of molecular methods in the prevention of nosocomial methicillin-resistant Staphylococcus aureus clusters in cancer patients. Am J Infect Control. 2008 Nov; 36(9):656-60.
    View in: PubMed
    Score: 0.081
  100. Role of ethylene diamine tetra-acetic acid (EDTA) in catheter lock solutions: EDTA enhances the antifungal activity of amphotericin B lipid complex against Candida embedded in biofilm. Int J Antimicrob Agents. 2008 Dec; 32(6):515-8.
    View in: PubMed
    Score: 0.081
  101. Human herpesvirus-6 DNAemia in immunosuppressed adult patients with leukemia at risk for mold infection. Haematologica. 2008 Jan; 93(1):157-8.
    View in: PubMed
    Score: 0.077
  102. Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters. Eur J Clin Microbiol Infect Dis. 2007 Aug; 26(8):549-56.
    View in: PubMed
    Score: 0.075
  103. Risk of bioaerosol contamination with Aspergillus species before and after cleaning in rooms filtered with high-efficiency particulate air filters that house patients with hematologic malignancy. Infect Control Hosp Epidemiol. 2007 Sep; 28(9):1066-70.
    View in: PubMed
    Score: 0.074
  104. Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer. Cancer. 2007 Jun 15; 109(12):2615-22.
    View in: PubMed
    Score: 0.074
  105. Correlation between early clinical response after catheter removal and diagnosis of catheter-related bloodstream infection. Diagn Microbiol Infect Dis. 2007 Aug; 58(4):453-7.
    View in: PubMed
    Score: 0.074
  106. Orthopaedic metal devices coated with a novel antiseptic dye for the prevention of bacterial infections. Int J Antimicrob Agents. 2007 May; 29(5):593-6.
    View in: PubMed
    Score: 0.072
  107. Catheter-related Staphylococcus aureus bacteremia in cancer patients: high rate of complications with therapeutic implications. Medicine (Baltimore). 2007 Jan; 86(1):54-60.
    View in: PubMed
    Score: 0.072
  108. Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters. Antimicrob Agents Chemother. 2006 Oct; 50(10):3283-8.
    View in: PubMed
    Score: 0.071
  109. Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients. Cancer. 2006 May 01; 106(9):1967-73.
    View in: PubMed
    Score: 0.069
  110. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis. 2006 May 15; 42(10):1398-403.
    View in: PubMed
    Score: 0.068
  111. Chest tube-related empyema due to methicillin-resistant Staphylococcus aureus: could the chest tube be coated with antiseptics? Infect Control Hosp Epidemiol. 2006 Feb; 27(2):195-7.
    View in: PubMed
    Score: 0.067
  112. Vancomycin-resistant Enterococcus faecium: catheter colonization, esp gene, and decreased susceptibility to antibiotics in biofilm. Antimicrob Agents Chemother. 2005 Dec; 49(12):5046-50.
    View in: PubMed
    Score: 0.067
  113. Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect Dis. 2005 Dec; 5(12):775-85.
    View in: PubMed
    Score: 0.067
  114. Cytomegalovirus pneumonia in patients with lymphoma. Cancer. 2005 Sep 15; 104(6):1213-20.
    View in: PubMed
    Score: 0.066
  115. Catheter-related vancomycin-resistant Enterococcus faecium bacteremia: clinical and molecular epidemiology. Infect Control Hosp Epidemiol. 2005 Jul; 26(7):658-61.
    View in: PubMed
    Score: 0.065
  116. Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer. Cancer. 2005 Jul 01; 104(1):205-12.
    View in: PubMed
    Score: 0.065
  117. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis. Cancer. 2005 Jun 01; 103(11):2334-7.
    View in: PubMed
    Score: 0.064
  118. Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens. Clin Infect Dis. 2005 Feb 01; 40(3):374-80.
    View in: PubMed
    Score: 0.063
  119. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections. Cancer. 2004 Dec 15; 101(12):2859-65.
    View in: PubMed
    Score: 0.062
  120. Differential quantitative blood cultures for the diagnosis of catheter-related bloodstream infections associated with short- and long-term catheters: a prospective study. Diagn Microbiol Infect Dis. 2004 Nov; 50(3):167-72.
    View in: PubMed
    Score: 0.062
  121. Multiple-species candidemia in patients with cancer. Cancer. 2004 Oct 15; 101(8):1860-5.
    View in: PubMed
    Score: 0.062
  122. Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin. Antimicrob Agents Chemother. 2004 Sep; 48(9):3583-5.
    View in: PubMed
    Score: 0.061
  123. Central venous catheter-related bacteremia due to gram-negative bacilli: significance of catheter removal in preventing relapse. Infect Control Hosp Epidemiol. 2004 Aug; 25(8):646-9.
    View in: PubMed
    Score: 0.061
  124. Relationship between myalgias/arthralgias occurring in patients receiving quinupristin/dalfopristin and biliary dysfunction. J Antimicrob Chemother. 2004 Jun; 53(6):1105-8.
    View in: PubMed
    Score: 0.060
  125. Management of central venous catheters in patients with cancer and candidemia. Clin Infect Dis. 2004 Apr 15; 38(8):1119-27.
    View in: PubMed
    Score: 0.059
  126. Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infections. J Antimicrob Chemother. 2004 Apr; 53(4):646-9.
    View in: PubMed
    Score: 0.059
  127. Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis. 2004; 36(8):564-9.
    View in: PubMed
    Score: 0.058
  128. In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob Agents Chemother. 2003 Nov; 47(11):3580-5.
    View in: PubMed
    Score: 0.058
  129. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime. Cancer. 2003 Sep 01; 98(5):1039-47.
    View in: PubMed
    Score: 0.057
  130. Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies. Cancer. 2003 Jul 15; 98(2):292-9.
    View in: PubMed
    Score: 0.056
  131. International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship. Elife. 2023 01 30; 12.
    View in: PubMed
    Score: 0.055
  132. Fungal sinusitis in the immunocompetent patient: risk factors and surgical management. Surg Infect (Larchmt). 2003; 4(2):199-204.
    View in: PubMed
    Score: 0.054
  133. Minocycline-ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer. Clin Infect Dis. 2003 Jan 01; 36(1):116-9.
    View in: PubMed
    Score: 0.054
  134. Skin lesions associated with Fusarium infection. J Am Acad Dermatol. 2002 Nov; 47(5):659-66.
    View in: PubMed
    Score: 0.054
  135. Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer. Infect Control Hosp Epidemiol. 2002 Sep; 23(9):532-7.
    View in: PubMed
    Score: 0.053
  136. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am J Med. 2002 Apr 01; 112(5):380-5.
    View in: PubMed
    Score: 0.052
  137. Diagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of aspergillus in BAL. Chest. 2002 Apr; 121(4):1171-6.
    View in: PubMed
    Score: 0.052
  138. Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer. Infect Control Hosp Epidemiol. 2002 Feb; 23(2):102-3.
    View in: PubMed
    Score: 0.051
  139. Efficacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbits. Antimicrob Agents Chemother. 2002 Feb; 46(2):327-32.
    View in: PubMed
    Score: 0.051
  140. Masking of neutropenic patients on transport from hospital rooms is associated with a decrease in nosocomial aspergillosis during construction. Infect Control Hosp Epidemiol. 2002 Jan; 23(1):41-3.
    View in: PubMed
    Score: 0.051
  141. Treatment of vancomycin-resistant enterococcal infections in the immunocompromised host: quinupristin-dalfopristin in combination with minocycline. Antimicrob Agents Chemother. 2001 Nov; 45(11):3202-4.
    View in: PubMed
    Score: 0.050
  142. Prognostic Value of Procalcitonin, C-Reactive Protein, and Lactate Levels in Emergency Evaluation of Cancer Patients with Suspected Infection. Cancers (Basel). 2021 Aug 13; 13(16).
    View in: PubMed
    Score: 0.049
  143. Invasive pulmonary aspergillosis in patients with solid tumours: risk factors and predictors of clinical outcomes. Ann Med. 2018 12; 50(8):713-720.
    View in: PubMed
    Score: 0.041
  144. Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center. Oncologist. 2012; 17(10):1329-36.
    View in: PubMed
    Score: 0.026
  145. Outbreak of community-acquired methicillin-resistant Staphylococcus aureus skin infections among health care workers in a cancer center. Am J Infect Control. 2011 Mar; 39(2):112-7.
    View in: PubMed
    Score: 0.024
  146. Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis. Medicine (Baltimore). 2010 Jul; 89(4):236-244.
    View in: PubMed
    Score: 0.023
  147. Clinical experience of linezolid in bone marrow transplantation patients. J Pharm Pract. 2010 Aug; 23(4):352-7.
    View in: PubMed
    Score: 0.022
  148. Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab. Biol Blood Marrow Transplant. 2010 Sep; 16(9):1265-71.
    View in: PubMed
    Score: 0.022
  149. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer. 2009 Oct 15; 115(20):4745-52.
    View in: PubMed
    Score: 0.022
  150. Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. Clin Infect Dis. 2007 Jan 01; 44(1):2-12.
    View in: PubMed
    Score: 0.018
  151. Invasive aspergillosis in patients with solid tumors. Cancer. 2004 Nov 15; 101(10):2300-2.
    View in: PubMed
    Score: 0.015
  152. Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus. Diagn Microbiol Infect Dis. 2003 May; 46(1):25-8.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.